QP-LI1

N/A

Report date: 2023/01/08 11:27:08
NME

Base Information

Drug NameQP-LI1
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interference
TargetsNot applicable
Therapy Area/IndicationsRejection of lung transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiocon LtdQuark Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesQuark Pharmaceuticals IncBiocon Ltd
Inactive CompaniesN/A
Active IndicationsRejection of lung transplantation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A